BFRI
Biofrontera IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$11.53M
P/E Ratio
—
EPS
$-1.04
Beta
0.64
52W High
$1.19
52W Low
$0.54
50-Day MA
$0.88
200-Day MA
$0.88
Dividend Yield
—
Profit Margin
-25.30%
Forward P/E
13.64
PEG Ratio
—
About Biofrontera Inc
Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.
Fundamentals
| Revenue (TTM) | $41.70M |
| Gross Profit (TTM) | $30.74M |
| EBITDA | $-11.21M |
| Operating Margin | 26.70% |
| Return on Equity | -141.30% |
| Return on Assets | -28.00% |
| Revenue/Share (TTM) | $4.10 |
| Book Value | $0.90 |
| Price-to-Book | 1.07 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 0.263 |
| EV/EBITDA | -0.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 36.20% |
| Shares Outstanding | $11.65M |
| Float | $7.95M |
| % Insiders | 14.12% |
| % Institutions | 23.68% |
Analyst Ratings
Consensus ($6.00 target)
2
BuyData last updated: 4/7/2026